UnitedHealth is trying to calm investor nerves with a memo full of optimism and disclaimers. CEO Stephen Hemsley, freshly ...

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth ...

The health insurer has suffered mounting problems and backlash since the fatal shooting of former CEO Brian Thompson.

UnitedHealth said that Hemsley intends to stay on as CEO for at least three years. Its governance committee reviews and ...

An internal document reveals how UnitedHealth Group's leadership prepared to downplay complaints about its business practices ...

Piper Sandler sharply lowered its price target on UnitedHealth Group Incorporated (NYSE:UNH) to $353 from $552, while ...

Stephen Hemsley previously served as CEO from 2006 through 2017 and has chaired the UnitedHealth Group board since 2017.

UnitedHealth Group faces short-term challenges, but strong fundamentals, undervaluation, and long-term growth potential make ...

UnitedHealth’s board approved Stephen Hemsley’s jaw-dropping $60 million stock option package despite investor concerns over ...

Newly back in the CEO chair at UnitedHealth Group, Stephen Hemsley on Monday vowed to address a series of lightning-rod ...

Takeaways: other insurers are challenged but UHG, for 40 years the best managed of the lot, is stumbling and falling into a hole; it hasn’t moved beyond ‘squeezing the rock’ of MLR and reducing care ...